Inhibition of protein synthesis in ehrlich ascites-tumour cells by the phenanthrene alkaloids tylophorine, tylocrebrine and cryptopleurine

The phenanthroindolizidine alkaloids tylophorine and tylocrebrine and the phenanthroquinolizidine alkaloid cryptopleurine inhibit incorporation of leucine into protein in Ehrlich ascites-tumour cells by 50% at 1 × 10 −6 M, 2 × 10 −7 M, and 2 × 10 −8 M respectively, but do not inhibit incorporation o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 1968-04, Vol.31 (1), p.104-109
Hauptverfasser: Donaldson, Gail R., Atkinson, M.R., Murray, A.W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 109
container_issue 1
container_start_page 104
container_title Biochemical and biophysical research communications
container_volume 31
creator Donaldson, Gail R.
Atkinson, M.R.
Murray, A.W.
description The phenanthroindolizidine alkaloids tylophorine and tylocrebrine and the phenanthroquinolizidine alkaloid cryptopleurine inhibit incorporation of leucine into protein in Ehrlich ascites-tumour cells by 50% at 1 × 10 −6 M, 2 × 10 −7 M, and 2 × 10 −8 M respectively, but do not inhibit incorporation of uracil into nucleic acids at 10 −5 M. Cryptopleurine inhibits leucine incorporation into protein in a cell-free system from Ehrlich cells, but at 10 −5 M does not inhibit protein synthesis in Escherichia coli.
doi_str_mv 10.1016/0006-291X(68)90037-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_84854883</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0006291X68900375</els_id><sourcerecordid>84854883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c272t-e50bd57596d9bce1229d23c42dab9f282b7d3813e2240d829edc986ab37d31f93</originalsourceid><addsrcrecordid>eNp9UV1rFTEQDaLU2-o_UMiTKLg1yWb3Ji-CFKuFgi8VfAv5mGWje5M1yRb2L_irzfZe-tin4cycM8M5g9AbSi4pof0nQkjfMEl_ve_FB0lIu2-6Z2hHiSQNo4Q_R7tHykt0nvNvQijlvTxDZ1z0UnK2Q_9uwuiNLz4GHAc8p1jAB5zXUEbIPuMKYEyTtyPW2foCuSnLIS4JW5imjM2KKxPPIwRdNQkCYD390VP0LuOyTnEeY_IBPj4Am8BsCOvgsE3rXOI8wbK1XqEXg54yvD7VC_Tz-uvd1ffm9se3m6svt41le1Ya6Ihx3b6TvZPGAmVMOtZazpw2cmCCmb1rBW2BMU6cYBKclaLXpq19Osj2Ar077q1m_y6Qizr4vJnRAeKSleCi40K0lciPRJtizgkGNSd_0GlVlKjtBWrLV235ql6ohxeorsrenvYv5gDuUXTKvM4_H-dQTd57SKrmCsGC8wlsUS76pw_8B9DDmig</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>84854883</pqid></control><display><type>article</type><title>Inhibition of protein synthesis in ehrlich ascites-tumour cells by the phenanthrene alkaloids tylophorine, tylocrebrine and cryptopleurine</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Donaldson, Gail R. ; Atkinson, M.R. ; Murray, A.W.</creator><creatorcontrib>Donaldson, Gail R. ; Atkinson, M.R. ; Murray, A.W.</creatorcontrib><description>The phenanthroindolizidine alkaloids tylophorine and tylocrebrine and the phenanthroquinolizidine alkaloid cryptopleurine inhibit incorporation of leucine into protein in Ehrlich ascites-tumour cells by 50% at 1 × 10 −6 M, 2 × 10 −7 M, and 2 × 10 −8 M respectively, but do not inhibit incorporation of uracil into nucleic acids at 10 −5 M. Cryptopleurine inhibits leucine incorporation into protein in a cell-free system from Ehrlich cells, but at 10 −5 M does not inhibit protein synthesis in Escherichia coli.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/0006-291X(68)90037-5</identifier><identifier>PMID: 4869942</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alkaloids - pharmacology ; Animals ; Bacterial Proteins - biosynthesis ; Carbon Isotopes ; Carcinoma, Ehrlich Tumor - metabolism ; Cell-Free System ; Depression, Chemical ; Escherichia coli - metabolism ; Indolizines - pharmacology ; Leucine - metabolism ; Neoplasm Proteins - biosynthesis ; Nucleotides - biosynthesis ; Phenanthrenes - pharmacology ; Quinolizines - pharmacology ; Uracil - metabolism</subject><ispartof>Biochemical and biophysical research communications, 1968-04, Vol.31 (1), p.104-109</ispartof><rights>1968</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c272t-e50bd57596d9bce1229d23c42dab9f282b7d3813e2240d829edc986ab37d31f93</citedby><cites>FETCH-LOGICAL-c272t-e50bd57596d9bce1229d23c42dab9f282b7d3813e2240d829edc986ab37d31f93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0006-291X(68)90037-5$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/4869942$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Donaldson, Gail R.</creatorcontrib><creatorcontrib>Atkinson, M.R.</creatorcontrib><creatorcontrib>Murray, A.W.</creatorcontrib><title>Inhibition of protein synthesis in ehrlich ascites-tumour cells by the phenanthrene alkaloids tylophorine, tylocrebrine and cryptopleurine</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>The phenanthroindolizidine alkaloids tylophorine and tylocrebrine and the phenanthroquinolizidine alkaloid cryptopleurine inhibit incorporation of leucine into protein in Ehrlich ascites-tumour cells by 50% at 1 × 10 −6 M, 2 × 10 −7 M, and 2 × 10 −8 M respectively, but do not inhibit incorporation of uracil into nucleic acids at 10 −5 M. Cryptopleurine inhibits leucine incorporation into protein in a cell-free system from Ehrlich cells, but at 10 −5 M does not inhibit protein synthesis in Escherichia coli.</description><subject>Alkaloids - pharmacology</subject><subject>Animals</subject><subject>Bacterial Proteins - biosynthesis</subject><subject>Carbon Isotopes</subject><subject>Carcinoma, Ehrlich Tumor - metabolism</subject><subject>Cell-Free System</subject><subject>Depression, Chemical</subject><subject>Escherichia coli - metabolism</subject><subject>Indolizines - pharmacology</subject><subject>Leucine - metabolism</subject><subject>Neoplasm Proteins - biosynthesis</subject><subject>Nucleotides - biosynthesis</subject><subject>Phenanthrenes - pharmacology</subject><subject>Quinolizines - pharmacology</subject><subject>Uracil - metabolism</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1968</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UV1rFTEQDaLU2-o_UMiTKLg1yWb3Ji-CFKuFgi8VfAv5mGWje5M1yRb2L_irzfZe-tin4cycM8M5g9AbSi4pof0nQkjfMEl_ve_FB0lIu2-6Z2hHiSQNo4Q_R7tHykt0nvNvQijlvTxDZ1z0UnK2Q_9uwuiNLz4GHAc8p1jAB5zXUEbIPuMKYEyTtyPW2foCuSnLIS4JW5imjM2KKxPPIwRdNQkCYD390VP0LuOyTnEeY_IBPj4Am8BsCOvgsE3rXOI8wbK1XqEXg54yvD7VC_Tz-uvd1ffm9se3m6svt41le1Ya6Ihx3b6TvZPGAmVMOtZazpw2cmCCmb1rBW2BMU6cYBKclaLXpq19Osj2Ar077q1m_y6Qizr4vJnRAeKSleCi40K0lciPRJtizgkGNSd_0GlVlKjtBWrLV235ql6ohxeorsrenvYv5gDuUXTKvM4_H-dQTd57SKrmCsGC8wlsUS76pw_8B9DDmig</recordid><startdate>19680405</startdate><enddate>19680405</enddate><creator>Donaldson, Gail R.</creator><creator>Atkinson, M.R.</creator><creator>Murray, A.W.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19680405</creationdate><title>Inhibition of protein synthesis in ehrlich ascites-tumour cells by the phenanthrene alkaloids tylophorine, tylocrebrine and cryptopleurine</title><author>Donaldson, Gail R. ; Atkinson, M.R. ; Murray, A.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c272t-e50bd57596d9bce1229d23c42dab9f282b7d3813e2240d829edc986ab37d31f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1968</creationdate><topic>Alkaloids - pharmacology</topic><topic>Animals</topic><topic>Bacterial Proteins - biosynthesis</topic><topic>Carbon Isotopes</topic><topic>Carcinoma, Ehrlich Tumor - metabolism</topic><topic>Cell-Free System</topic><topic>Depression, Chemical</topic><topic>Escherichia coli - metabolism</topic><topic>Indolizines - pharmacology</topic><topic>Leucine - metabolism</topic><topic>Neoplasm Proteins - biosynthesis</topic><topic>Nucleotides - biosynthesis</topic><topic>Phenanthrenes - pharmacology</topic><topic>Quinolizines - pharmacology</topic><topic>Uracil - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Donaldson, Gail R.</creatorcontrib><creatorcontrib>Atkinson, M.R.</creatorcontrib><creatorcontrib>Murray, A.W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Donaldson, Gail R.</au><au>Atkinson, M.R.</au><au>Murray, A.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of protein synthesis in ehrlich ascites-tumour cells by the phenanthrene alkaloids tylophorine, tylocrebrine and cryptopleurine</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>1968-04-05</date><risdate>1968</risdate><volume>31</volume><issue>1</issue><spage>104</spage><epage>109</epage><pages>104-109</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>The phenanthroindolizidine alkaloids tylophorine and tylocrebrine and the phenanthroquinolizidine alkaloid cryptopleurine inhibit incorporation of leucine into protein in Ehrlich ascites-tumour cells by 50% at 1 × 10 −6 M, 2 × 10 −7 M, and 2 × 10 −8 M respectively, but do not inhibit incorporation of uracil into nucleic acids at 10 −5 M. Cryptopleurine inhibits leucine incorporation into protein in a cell-free system from Ehrlich cells, but at 10 −5 M does not inhibit protein synthesis in Escherichia coli.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>4869942</pmid><doi>10.1016/0006-291X(68)90037-5</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 1968-04, Vol.31 (1), p.104-109
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_84854883
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Alkaloids - pharmacology
Animals
Bacterial Proteins - biosynthesis
Carbon Isotopes
Carcinoma, Ehrlich Tumor - metabolism
Cell-Free System
Depression, Chemical
Escherichia coli - metabolism
Indolizines - pharmacology
Leucine - metabolism
Neoplasm Proteins - biosynthesis
Nucleotides - biosynthesis
Phenanthrenes - pharmacology
Quinolizines - pharmacology
Uracil - metabolism
title Inhibition of protein synthesis in ehrlich ascites-tumour cells by the phenanthrene alkaloids tylophorine, tylocrebrine and cryptopleurine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T05%3A16%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20protein%20synthesis%20in%20ehrlich%20ascites-tumour%20cells%20by%20the%20phenanthrene%20alkaloids%20tylophorine,%20tylocrebrine%20and%20cryptopleurine&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Donaldson,%20Gail%20R.&rft.date=1968-04-05&rft.volume=31&rft.issue=1&rft.spage=104&rft.epage=109&rft.pages=104-109&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/0006-291X(68)90037-5&rft_dat=%3Cproquest_cross%3E84854883%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=84854883&rft_id=info:pmid/4869942&rft_els_id=0006291X68900375&rfr_iscdi=true